The Brand Mason’s Peer Review: 7 Common Cents Naming Insights

Editor’s note: The following is a guest post by The Brand Mason (Steven Mason), a marketing, communications and naming artisan. Follow on twitter: @thebrandmason Over the past 22 years, Steven has been a marketing executive at—and consultant to—public and private Internet security/networking, enterprise software, B2B platform, e-Business firms, and consumer packaged goods (CPG) firms, as [...]

Of Sprints and Marathons

“Life is often compared to a marathon, but I think it is more like being a sprinter; long stretches of hard work punctuated by brief moments in which we are given the opportunity to perform at our best” - Michael Johnson Priority 1 So we've done it. We've disturbed inertia and finally have notsocommoncents up and [...]

Shame on you Merck

Merck continues it's stellar string of "achievements" by creating a fraudulent peer-review journal to publish data that casts a favorable light on Fosamax and other drugs. I'm not surprised at this course off action from Merck, a company that hasn't had a blockbuster drug in years. I am more furious at Elsevier, a respected academic journal publisher, that did NOT [...]